Diluted EPS came in at $-0.09, beat the $-0.11 consensus by $0.02.
Trailing eight quarters through Q4 2024
Common questions about Anixa Biosciences's Q4 2024 earnings report.
Anixa Biosciences (ANIX) reported Q4 2024 earnings on January 10, 2025 before market open.
Anixa Biosciences reported diluted EPS of $-0.09 for Q4 2024.
EPS beat the consensus estimate of $-0.11 by $0.02.
You can read the 10-K periodic report (0001493152-25-001787) directly on SEC EDGAR. The filing index links above go to sec.gov.